You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

CLINICAL TRIALS PROFILE FOR ACTIVASE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ACTIVASE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00250991 ↗	Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial	Completed	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 1/Phase 2	2003-07-01	The purpose of this study is determine the effects of using of a combination of two drugs--integrilin (eptifibatide) and activase (recombinant tissue plasminogen activator, rt-PA, or recombinant t-PA)--to dissolve blood clots in patients who have a stroke.
NCT00250991 ↗	Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial	Completed	University of Cincinnati	Phase 1/Phase 2	2003-07-01	The purpose of this study is determine the effects of using of a combination of two drugs--integrilin (eptifibatide) and activase (recombinant tissue plasminogen activator, rt-PA, or recombinant t-PA)--to dissolve blood clots in patients who have a stroke.
NCT00265005 ↗	Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants	Terminated	Genentech, Inc.	Phase 1	2005-06-01	The purpose of this study is to determine if alteplase is effective in dissolving a clot in a catheter in a large vein (central venous line or PICC line) or artery in infants less than 6 months of age.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ACTIVASE

Condition Name

Chart
Table

Condition Name for ACTIVASE
Intervention	Trials
Stroke	9
Ischemic Stroke	4
Venous Thrombosis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ACTIVASE
Intervention	Trials
Stroke	12
Ischemic Stroke	7
Ischemia	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ACTIVASE

Trials by Country

Map
Table

Trials by Country for ACTIVASE
Location	Trials
United States	170
Australia	10
Canada	10
China	6
Spain	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ACTIVASE
Location	Trials
California	11
Ohio	10
Illinois	8
Pennsylvania	8
Texas	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ACTIVASE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ACTIVASE
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	10
Phase 2/Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ACTIVASE
Clinical Trial Phase	Trials
Completed	15
Terminated	6
Withdrawn	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ACTIVASE

Sponsor Name

Chart
Table

Sponsor Name for ACTIVASE
Sponsor	Trials
Genentech, Inc.	14
National Institute of Neurological Disorders and Stroke (NINDS)	5
Johns Hopkins University	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ACTIVASE
Sponsor	Trials
Other	50
Industry	22
NIH	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.